Background illustration for clinical trials search

Paid Clinical Trials Newport

Discover 489 paid clinical trials in Newport, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Strategy for Improving Stroke Treatment Response

for
Ischemic Stroke
Location: Providence RI, Boston MA, Hartford CT, New Haven CT,
Sponsor: Translational Sciences, Inc.

Sex: All

Age: 18+

Code: NCT05948566

Phase 2, Recruiting

Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma

for
Follicular Lymphoma, Marginal Zone Lymphoma, B-cell Lymphoma
Location: Providence RI, New Brunswick NJ
Sponsor: Brown University

Sex: All

Age: 18+

Code: NCT04792502

Phase 2, Recruiting

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

for
Solid Tumors, Advanced Solid Tumors, Metastatic Solid Tumors
Location: Providence RI, Boston MA, Mineola NY, New York NY,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT05836324

Phase 1, Recruiting

Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control

for
Melanoma (Skin), Non-melanomatous Skin Cancer
Location: Providence RI, Philadelphia PA, Columbus OH, Wichita KS,
Sponsor: Rhode Island Hospital

Sex: All

Age: 18+

Code: NCT00295906

Recruiting

Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens

for
Leukemia, Myelodysplastic Syndromes,
Location: Providence RI, Hartford CT, Albany NY, Portland ME,
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 0 - 30

Code: NCT04968834

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for
Melanoma
Location: Providence RI, New Haven CT, Paramus NJ, Hackensack NJ,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase 3, Recruiting

A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Providence RI, New Haven CT, Toronto, Detroit MI,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06253130

Phase 1, Phase 2, Recruiting

A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Providence RI, New York NY, Fairfax VA, Toronto,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT05765851

Phase 1, Recruiting

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

for
Meningioma
Location: Providence RI, Boston MA, New York NY, Fairfax VA,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT07428616

Phase 2, Recruiting

A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Metastatic Castration-Resistant Prostate Cancer
Location: Providence RI, The Bronx NY, Montreal, Toronto,
Sponsor: Hoffmann-La Roche

Sex: Male

Age: 18+

Code: NCT07287150

Phase 2, Recruiting

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

for
Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma,
Location: Providence RI, New York NY, Fairfax VA, Cleveland OH,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06084481

Phase 1, Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

for
Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors
Location: Providence RI, Boston MA, Norwalk CT, New York NY,
Sponsor: Fore Biotherapeutics

Sex: All

Age: 8+

Code: NCT05503797

Phase 2, Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Providence RI, Boston MA, Burlington MA, New Haven CT,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase 3, Recruiting

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Providence RI, Boston MA, New Haven CT, New York NY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03972657

Phase 1, Phase 2, Recruiting

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

for
Neoplasms, Child, Adolescent
Location: Providence RI, New York NY, Washington D.C. DC,
Sponsor: Eli Lilly and Company

Sex: All

Age: 1 - 39

Code: NCT05999994

Phase 2, Recruiting

A New Clinical Model for the Engagement of Latinx Youth With Suicidal Behavior

for
Suicide Ideation, Suicidal Behaviors, Depressive Symptoms
Location: Providence RI
Sponsor: Bradley Hospital

Sex: All

Age: 12 - 18

Code: NCT06882798

Recruiting

Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence

for
Stress Urinary Incontinence, Urinary Incontinence,
Location: Providence RI, Philadelphia PA, Durham NC, Chicago IL,
Sponsor: NICHD Pelvic Floor Disorders Network

Sex: Female

Age: 21+

Code: NCT06480227

Recruiting

Accelerometer Measured Early Recovery After Prolapse Surgery

for
Pelvic Organ Prolapse, Pelvic Organ Prolapse (POP),
Location: Providence RI, Philadelphia PA, Durham NC, Chicago IL,
Sponsor: NICHD Pelvic Floor Disorders Network

Sex: Female

Age: 18 - 70+

Code: NCT07218016

Recruiting

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

for
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Location: East Providence RI, Boston MA, Great Neck NY,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT06072482

Phase 4, Recruiting

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

for
Focal Segmental Glomerulosclerosis
Location: East Providence RI, Mineola NY, Clifton Park NY,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 12+

Code: NCT07220083

Phase 3, Recruiting